AEterna Zentaris Inc (AEZS)

1.86
NASDAQ : Health Care
Prev Close 1.86
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.78 / 5.59
Avg Volume 2.90M
Exchange NASDAQ
Shares Outstanding 16.11M
Market Cap 30.77M
EPS -2.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Aeterna Zentaris Engages Advisors And Provides Update To Shareholders

Aeterna Zentaris Engages Advisors And Provides Update To Shareholders

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), announced today that the special committee of independent directors (the "Strategic Review Committee") has engaged a consulting firm and a financial...

IIROC Trading Halt - AEZS

IIROC Trading Halt - AEZS

Aeterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017

Aeterna Zentaris To Announce Second Quarter 2017 Financial And Operating Results On August 10, 2017

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") will announce its second quarter 2017 financial and operating results after market close on Thursday, August 10, 2017.

Aeterna Zentaris Commences Legal Action Against David Dodd And Philip Theodore

Aeterna Zentaris Commences Legal Action Against David Dodd And Philip Theodore

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), announced today that it has filed a claim against the Company's former CEO David Dodd and its former General Counsel Philip Theodore (the "Defendants")...

Aeterna Zentaris Forms Strategic Review Committee And Appoints Michael Ward As CEO

Aeterna Zentaris Forms Strategic Review Committee And Appoints Michael Ward As CEO

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), announced today that it has formed a special committee of independent directors (the "Strategic Review Committee") to consider and evaluate various...

NDA For Macrilen™ For The Evaluation Of Growth Hormone Deficiency In Adults Granted December 30, 2017 PDUFA Date

NDA For Macrilen™ For The Evaluation Of Growth Hormone Deficiency In Adults Granted December 30, 2017 PDUFA Date

Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the "Company") today announced that it has been notified by the U.

Aeterna Zentaris Resubmits NDA For Macrilen™ For The Evaluation Of Growth Hormone Deficiency In Adults

Aeterna Zentaris Resubmits NDA For Macrilen™ For The Evaluation Of Growth Hormone Deficiency In Adults

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") today announced that it has resubmitted a new drug application ("NDA") to the U.

Aeterna Zentaris To Present At 2017 Marcum MicroCap Conference

Aeterna Zentaris Inc. (TSX: AEZS) (NASDAQ: AEZS) (the "Company") today announced that the Company's President and Chief Executive Officer, David Dodd, will present a corporate overview at the 2017 Marcum MicroCap Conference...

Aeterna Zentaris Announces Election Of Directors At 2017 Shareholders' Meeting

Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the "Company"), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health, today...

Aeterna Zentaris Reports First Quarter 2017 Financial And Operating Results

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), a specialty biopharmaceutical company engaged in developing and commercializing novel pharmaceutical therapies, today reported financial and operating...

Aeterna Zentaris To Announce First Quarter 2017 Financial And Operating Results On May 8, 2017

Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the "Company") will announce its first quarter 2017 financial and operating results after market close on Monday, May 8, 2017.

Tech Leads Nasdaq to a New Record; Congressional Funding Bill Boosts S&P 500

Tech Leads Nasdaq to a New Record; Congressional Funding Bill Boosts S&P 500

Wall Street ended its first session of May mostly higher as tech stocks boosted the Nasdaq and a congressional funding deal brought relief to the S&P 500.

Stocks Trade Higher, Financial Stocks on Watch After Trump Talks Banks

Stocks Trade Higher, Financial Stocks on Watch After Trump Talks Banks

Stocks are mostly higher on Monday after congressional leaders reach a deal to fund the federal government through the rest of the budget year.

Stocks Move Higher, Nasdaq at Records as Congress Makes Funding Deal

Stocks Move Higher, Nasdaq at Records as Congress Makes Funding Deal

Stocks turn green again on Monday morning after congressional leaders reach a deal to fund the federal government through the rest of the budget year.

IIROC Trade Resumption - AEZS

IIROC Trading Halt - AEZS

Aeterna Zentaris Announces That ZoptEC Phase 3 Clinical Study Of Zoptrex™ Did Not Achieve Its Primary Endpoint

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (the "Company") today announced that the ZoptEC Phase 3 clinical study of Zoptrex™ (zoptarelin doxorubicin) in women with locally advanced, recurrent or metastatic...

Aeterna Zentaris To Announce Top-Line Results Of The ZoptEC Phase 3 Clinical Study Of Zoptrex™

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") will announce the top-line results of the ZoptEC Phase 3 clinical study of Zoptrex™ (zoptarelin doxorubicin) in women with locally advanced, recurrent...

Aeterna Zentaris Announces Replacement At The Market Issuance Program

Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the "Company") announced today that it has entered into a new At Market Issuance Sales Agreement, dated April 27, 2017 (the "New ATM Sales Agreement"), with H.

Aeterna Zentaris Mails Management Information Circular In Connection With Annual Meeting Of Shareholders

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna Zentaris" or the "Company") today announced that it has mailed a Notice of Meeting and Management Information Circular (the "Meeting Materials") to the shareholders...

Dow Leads Wall Street as Financials Stocks Stage a Small Rebound

Dow Leads Wall Street as Financials Stocks Stage a Small Rebound

The Dow Jones Industrial Average shakes off recent weakness to post modest gains as a financials stocks stage a slight rebound.

U.S. Stocks Climb to Session Highs as Financials Make a Rebound

U.S. Stocks Climb to Session Highs as Financials Make a Rebound

Stocks add to earlier gains Thursday as the financial sector makes a slight rebound after recent weakness.

Stock Futures Pare Losses as U.S. Economy Grows Faster Than Anticipated in 4Q

Stock Futures Pare Losses as U.S. Economy Grows Faster Than Anticipated in 4Q

Stock futures pare losses on Thursday after the U.S. economy grows at a slightly faster pace than anticipated over the last three months of 2016.

Aeterna Zentaris Intends To File NDA With Respect To Macrilen™ In Third Quarter Of 2017

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") today announced that, following its meeting with the U.

Aeterna Zentaris Announces At The Market Issuance Program

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS): All dollar amounts are stated in US$ Aeterna Zentaris Inc.

Aeterna Zentaris Reports Fourth Quarter And Full-Year 2016 Financial And Operating Results

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), a specialty biopharmaceutical company engaged in developing and commercializing novel treatments in oncology and endocrinology, today reported financial and...

Aeterna Zentaris Announces EMA Pediatric Committee Agreement On The Pediatric Investigation Plan For Macrilen™

Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the "Company") announced today that the Pediatric Committee ("PDCO") of the European Medicines Agency ("EMA") agreed to the Company's Pediatric Investigation Plan...

Aeterna Zentaris To Announce Fourth Quarter And Full-Year 2016 Financial And Operating Results On March 15, 2017

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") will announce its fourth quarter and full-year 2016 financial and operating results after market close on Wednesday, March 15, 2017.